Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Progress on norovirus vaccine research: public health considerations and future directions
  • Published Date:
    August 27 2018
  • Source:
    Expert Rev Vaccines. 17(9):773-784
  • Language:
    English
Filetype[PDF-330.42 KB]


Details:
  • Alternative Title:
    Expert Rev Vaccines
  • Personal Author:
  • Description:
    Introduction:

    Noroviruses are the leading cause of foodborne illness worldwide, account for approximately one-fifth of acute gastroenteritis (AGE) cases globally, and cause a substantial economic burden. Candidate norovirus vaccines are in development, but there is currently no licensed vaccine.

    Areas covered:

    Noroviruses cause approximately 684 million cases and 212,000 deaths per year across all age groups, though burden estimates vary by study and region. Challenges to vaccine research include substantial and rapidly evolving genetic diversity, short-term and homotypic immunity to infection, and the absence of a single, well-established correlate of protection. Nonetheless, several norovirus vaccine candidates are currently in development, utilizing virus-like particles (VLPs), P particles, and recombinant adenoviruses. Of these, a bivalent GI.1/GII.4 VLP-based intramuscular vaccine (Phase IIb) and GI.1 oral vaccine (Phase I) are in clinical trials.

    Expert Commentary:

    A norovirus vaccine should target high-risk populations, including the young and the elderly, and protect them against the most common circulating norovirus strains. A norovirus vaccine would be a powerful tool in the prevention and control of norovirus while lessening the burden of AGE worldwide. However, more robust burden and cost estimates are needed to justify investments in and guide norovirus vaccine development.

  • Subject:
  • Pubmed ID:
    30092671
  • Pubmed Central ID:
    PMC6410563
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control
    Personal Author:
    Lopman, Benjamin A.; Steele, Duncan; Kirkwood, Carl D.; Parashar, Umesh D.;
    Published Date:
    Apr 26 2016
    Source:
    PLoS Med. 13(4).
    Description:
    Globally, norovirus is associated with approximately one-fifth of all diarrhea cases, with similar prevalence in both children and adults, and is estimated to cause over 200,000 deaths annually in developing countries. Norovirus is an important patho...
    File Type:
    Filetype[PDF - 223.28 KB]
  2. Annual Report to the Secretary, Department of Health and Human Services, 2014
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of Infectious Diseases. Board of Scientific Counselors. Food Safety Modernization Act Surveillance Working Group.
    Published Date:
    4/7/2015
    Description:
    The Food Safety Modernization Act of 2010 (FSMA), signed into law on January 4th, 2011, authorized the Centers for Disease Control and Prevention (CDC) to create a diverse working group of experts and stakeholders to provide routine and ongoing guida...
    File Type:
    Filetype[PDF - 1.26 MB]
  3. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations
    Personal Author:
    Aliabadi, Negar; Lopman, Ben A; Parashar, Umesh D; Hall, Aron J;
    Published Date:
    July 29 2015
    Source:
    Expert Rev Vaccines. 14(9):1241-1253
    Description:
    Human norovirus infection causes significant medical and financial costs in the USA and abroad. Some populations, including young children, the elderly, and the immunocompromised, are at heightened risk of infection with this virus and subsequent com...
    File Type:
    Filetype[PDF - 109.96 KB]
  4. New insights into the global burden of noroviruses and opportunities for prevention
    Personal Author:
    Hall, Aron J.; Glass, Roger I.; Parashar, Umesh D.;
    Published Date:
    May 03 2016
    Source:
    Expert Rev Vaccines. 15(8):949-951.
    File Type:
    Filetype[PDF - 282.45 KB]
  5. Progress report on a CDC framework for preventing infectious diseases : sustaining the essentials and innovating for the future : October 2011-May 2013.
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    May 2013
    Description:
    A CDC Framework for Preventing Infectious Diseases: Sustaining the Essentials and Innovating for the Future (CDC's ID Framework) was issued in October 2011 as a roadmap for improving our ability to prevent known infectious diseases and to recognize a...
    File Type:
    Filetype[PDF - 623.83 KB]